Cargando…
The Importance of Cellular Metabolic Pathways in Pathogenesis and Selective Treatments of Hematological Malignancies
Despite recent advancements in the treatment of hematologic malignancies and the emergence of newer and more sophisticated therapeutic approaches such as immunotherapy, long-term overall survival remains unsatisfactory. Metabolic alteration, as an important hallmark of cancer cells, not only contrib...
Autores principales: | Soltani, Mojdeh, Zhao, Yue, Xia, Zhijia, Ganjalikhani Hakemi, Mazdak, Bazhin, Alexandr V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636012/ https://www.ncbi.nlm.nih.gov/pubmed/34868994 http://dx.doi.org/10.3389/fonc.2021.767026 |
Ejemplares similares
-
Editorial: Cellular and Molecular Mechanisms of Immune Checkpoint Blockers in Anti-leukemia/Lymphoma Immune Therapy
por: Ganjalikhani-Hakemi, Mazdak, et al.
Publicado: (2022) -
PD-L1 stimulation can promote proliferation and survival of leukemic cells by influencing glucose and fatty acid metabolism in acute myeloid leukemia
por: Soltani, Mojdeh, et al.
Publicado: (2023) -
The Role of TIM-3 in Hepatocellular Carcinoma: A Promising Target for Immunotherapy?
por: Ganjalikhani Hakemi, Mazdak, et al.
Publicado: (2020) -
Comparison of Laboratory Methods for the Clinical Follow Up of Checkpoint Blockade Therapies in Leukemia: Current Status and Challenges Ahead
por: Aru, Basak, et al.
Publicado: (2022) -
TIM-3/Gal-9 interaction affects glucose and lipid metabolism in acute myeloid leukemia cell lines
por: Rezaei, Mahnaz, et al.
Publicado: (2023)